Acute demyelinating lesions with restricted diffusion in multiple sclerosis

Background and objectives: It is widely accepted that typical acute demyelinating lesions in relapsing–remitting multiple sclerosis (RRMS) exhibit vasogenic edema with increased diffusion, as demonstrated by an increased apparent diffusion coefficient on MRI. In contrast, acute ischemic lesions demonstrate cytotoxic edema with restricted diffusion. Recent reports have documented selected cases of acute demyelinating lesions exhibiting restricted diffusion (ADLRD) in MS. We aimed to assess the morphologies, distributions, signal characteristics and changes over time of nine ADLRD. An additional goal was to obtain clinical correlations and relate our findings to all previously published case reports describing ADLRD. Methods: A retrospective case series study was performed at two academic centers. MRI characteristics of nine ADLRD found in six RRMS patients were compared with typical active symptomatic contrast-enhancing lesions with increased or normal diffusion in control RRMS patients. Results: The average size of ADLRD was not significantly different from typical lesions. A periventricular location and faint signal on T2-weighted images were significantly more common for ADLRD compared with typical lesions. Two patients with ADLRD on initial MRI exhibited new ADLRD on their follow up scans. Conclusion: Our results and review of prior published cases suggest that ADLRD represent a new variant of MS lesion. The restricted diffusion that is a characteristic of ADLRD on MRI is a new challenge in the differential diagnosis of stroke in young adults. The pathogenesis of ADLRD remains to be understood.

[1]  B E Kendall,et al.  Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis. , 1988, Brain : a journal of neurology.

[2]  J. Oger,et al.  Multiple sclerosis , 1988, Neurology.

[3]  G. Arendt,et al.  Association of Crohn's Disease and Multiple Sclerosis. Is There a Common Background? , 1992, Journal of clinical gastroenterology.

[4]  K. Marro,et al.  Experimental allergic encephalomyelitis in non-human primates: diffusion imaging of acute and chronic brain lesions , 1995, Multiple sclerosis.

[5]  G. Albers,et al.  Diffusion-weighted MRI for evaluation of acute stroke , 1998, Neurology.

[6]  T. Ptak,et al.  Investigation of apparent diffusion coefficient and diffusion tensor anisotrophy in acute and chronic multiple sclerosis lesions. , 1999, AJNR. American journal of neuroradiology.

[7]  Cheuk Y. Tang,et al.  Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images. , 2000, AJR. American journal of roentgenology.

[8]  J A Maldjian,et al.  Multiple sclerosis: comparison of trace apparent diffusion coefficients with MR enhancement pattern of lesions. , 2000, AJNR. American journal of neuroradiology.

[9]  P. Schaefer Diffusion-Weighted Imaging as a Problem-Solving Tool in the Evaluation of Patients with Acute Strokelike Syndromes , 2000, Topics in magnetic resonance imaging : TMRI.

[10]  J H Simon,et al.  Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. , 2000, The New England journal of medicine.

[11]  F. Ståhlberg,et al.  The value of b required to avoid T2 shine-through from old lacunar infarcts in diffusion-weighted imaging , 2001, Neuroradiology.

[12]  E. Oldfield,et al.  Vascular Endothelial Growth Factor Is Expressed in Multiple Sclerosis Plaques and Can Induce Inflammatory Lesions in Experimental Allergic Encephalomyelitis Rats , 2002, Journal of neuropathology and experimental neurology.

[13]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[14]  R. Floris,et al.  Diffusion of water in large demyelinating lesions: a follow-up study , 2002, Neuroradiology.

[15]  À. Rovira,et al.  Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report. , 2002, AJNR. American journal of neuroradiology.

[16]  Hans Lassmann,et al.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions , 2002, Journal of the Neurological Sciences.

[17]  F. Jolesz,et al.  MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals , 2003, Neurology.

[18]  W. Smoker,et al.  Diffusion-weighted imaging of acute excitotoxic brain injury. , 2005, AJNR. American journal of neuroradiology.

[19]  Robert Zivadinov,et al.  Clinical–Magnetic Resonance Imaging Correlations in Multiple Sclerosis , 2005, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[20]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[21]  O. Ciccarelli,et al.  Diffusion MRI in multiple sclerosis , 2005, Neurology.

[22]  J. Gillard,et al.  Diffusion-weighted MR Imaging of the brain , 2006 .

[23]  P. Remy,et al.  Diffusion-weighted MR imaging characteristics of an acute strokelike form of multiple sclerosis. , 2006, AJNR. American journal of neuroradiology.

[24]  M. Melbye,et al.  Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study. , 2006, Archives of neurology.

[25]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[26]  C. Decaestecker,et al.  Apparent Diffusion Coefficient and Cerebral Blood Volume in Brain Gliomas: Relation to Tumor Cell Density and Tumor Microvessel Density Based on Stereotactic Biopsies , 2008, American Journal of Neuroradiology.

[27]  T. Naidich,et al.  Central Nervous System Lymphoma Characterization by Diffusion‐Weighted Imaging and MR Spectroscopy , 2008, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[28]  A. Osborn Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome , 2010 .

[29]  M. Castillo,et al.  Use of Diffusion-Weighted Imaging to Evaluate the Initial Response of Progressive Multifocal Leukoencephalopathy to Highly Active Antiretroviral Therapy: Early Experience , 2010, American Journal of Neuroradiology.

[30]  C. Bassetti,et al.  Diffusion-weighted imaging in acute demyelinating myelopathy , 2012, Neuroradiology.

[31]  V. Jewells,et al.  Progressive tumefactive inflammatory central nervous system demyelinating disease in an acquired immunodeficiency syndrome patient treated with highly active antiretroviral therapy , 2011, Journal of NeuroVirology.

[32]  K. Balashov,et al.  Acute Multiple Sclerosis Lesion: Conversion of Restricted Diffusion Due to Vasogenic Edema , 2011, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[33]  Frederik Barkhof,et al.  Diffusion magnetic resonance imaging in multiple sclerosis. , 2011, Neuroimaging clinics of North America.